The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Abstract
When considering the pathological steps in the progression from cardiac overload towards the full clinical syndrome of heart failure, it is becoming increasingly clear that the extracellular matrix (ECM) is an important determinant in this process. Chronic pressure overload induces a number of structural alterations, not only hypertrophy of cardiomyocytes but also an increase in ECM proteins in the interstitium and perivascular regions of the myocardium. When this culminates in excessive fibrosis, myocardial compliance decreases and electrical conduction is affected. Altogether, fibrosis is associated with an increased risk of ventricular dysfunction and arrhythmias. Consequently, anti-fibrotic strategies are increasingly recognized as a promising approach in the prevention and treatment of heart failure. Thus, dissecting the molecular mechanisms underlying the development of cardiac fibrosis is of great scientific and therapeutic interest. In this review, we provide an overview of the available evidence supporting the general idea that fibrosis plays a causal role in deteriorating cardiac function. Next, we will delineate the signalling pathways importantly governed by transforming growth factor β (TGFβ) in the control of cardiac fibrosis. Finally, we will discuss the recent discovery that miRNAs importantly regulate cardiac fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“In this regard, silencing of the liver-specific miR-122 in monkeys recently resulted in a long-lasting lowering of plasma cholesterol levels.(85) A specific inhibitor of miR-122 is the first miRNA-targeted drug that has entered a human clinical trial, in patients infected with Hepatitis C.”
van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., Richardson, J. A., & Olson, E. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608791103 · Cited by 1,507
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
ECM remodeling in hypertensive heart disease
Berk, B. C., Fujiwara, K., & Lehoux, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31044 · Cited by 902
Sappino, A. P., Schürch, W., & Gabbiani, G. (1990) · PubMed · Cited by 833
Duisters, R. F., Tijsen, A. J., Schroen, B., Leenders, J. J., Lentink, V., van der Made, I., Herias, V., van Leeuwen, R. E., Schellings, M. W., Barenbrug, P., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.182535 · Cited by 816
Self-citationLiu, N., Bezprozvannaya, S., Williams, A. H., Qi, X., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Genes & Development · doi:10.1101/gad.1738708 · Cited by 790
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., & Lyons, K. M. (2003) · Development · doi:10.1242/dev.00505 · Cited by 713
TGF-?1 and angiotensin networking in cardiac remodeling
ROSENKRANZ, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.030 · Cited by 683
Duncan, M. R., Frazier, K. S., Abramson, S., Williams, S., Klapper, H., Huang, X., & Grotendorst, G. R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1774 · Cited by 631
Roy, S., Khanna, S., Hussain, S.-R. A., Biswas, S., Azad, A., Rink, C., Gnyawali, S., Shilo, S., Nuovo, G. J., & Sen, C. K. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp015 · Cited by 614
Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2002) · Circulation · doi:10.1161/01.cir.0000020689.12472.e0 · Cited by 609
Extracellular Matrix Remodeling in Heart Failure: A Role for De Novo Angiotensin II Generation
Weber, K. T. (1997) · Circulation · doi:10.1161/01.cir.96.11.4065 · Cited by 557
Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium.
Weber, K. T., Janicki, J. S., Shroff, S. G., Pick, R., Chen, R. M., & Bashey, R. I. (1988) · Circulation Research · doi:10.1161/01.res.62.4.757 · Cited by 556
Collagen Network of the Myocardium: Function, Structural Remodeling and Regulatory Mechanisms
Weber, K. T., Sun, Y., Tyagi, S. C., & Cleutjens, J. P. M. (1994) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1994.1036 · Cited by 521
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Chen, M. M., Lam, A., Abraham, J. A., Schreiner, G. F., & Joly, A. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1215 · Cited by 442
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14190 · Cited by 426
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload
Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40295 · Cited by 389
Small, E. M., Thatcher, J. E., Sutherland, L. B., Kinoshita, H., Gerard, R. D., Richardson, J. A., DiMaio, J. M., Sadek, H., Kuwahara, K., & Olson, E. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223172 · Cited by 373
Shi-Wen, X., Leask, A., & Abraham, D. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.002 · Cited by 369
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
Shan, H., Zhang, Y., Lu, Y., Zhang, Y., Pan, Z., Cai, B., Wang, N., Li, X., Feng, T., Hong, Y., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp130 · Cited by 349
ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling
Sano, Y., Harada, J., Tashiro, S., Gotoh-Mandeville, R., Maekawa, T., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8949 · Cited by 345
Zhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (2000) · Nature Medicine · doi:10.1038/75037 · Cited by 337
Force activates smooth muscle α-actin promoter activity through the Rho signaling pathway
Zhao, X.-H., Laschinger, C., Arora, P., Szászi, K., Kapus, A., & McCulloch, C. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.001586 · Cited by 329
Smads bind directly to the Jun family of AP-1 transcription factors
Liberati, N. T., Datto, M. B., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M., & Wang, X.-F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4844 · Cited by 327
Collagen expression in mechanically stimulated cardiac fibroblasts.
Carver, W., Nagpal, M. L., Nachtigal, M., Borg, T. K., & Terracio, L. (1991) · Circulation Research · doi:10.1161/01.res.69.1.116 · Cited by 317
Origin of Cardiac Fibroblasts and the Role of Periostin
Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., & Conway, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.201400 · Cited by 302
Rosenkranz, S., Flesch, M., Amann, K., Haeuseler, C., Kilter, H., Seeland, U., Schlüter, K.-D., & Böhm, M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00578.2001 · Cited by 300
Yokota, M., Ichihara, S., Lin, T.-L., Nakashima, N., & Yamada, Y. (2000) · Circulation · doi:10.1161/01.cir.101.24.2783 · Cited by 299
Lee, C. H., Shah, B., Moioli, E. K., & Mao, J. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43230 · Cited by 289
Lee, C. H., Shah, B., Moioli, E. K., & Mao, J. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci84508 · Cited by 280
Burstein, B., Libby, E., Calderone, A., & Nattel, S. (2008) · Circulation · doi:10.1161/circulationaha.107.748053 · Cited by 268
Nakajima, H., Nakajima, H. O., Salcher, O., Dittiè, A. S., Dembowsky, K., Jing, S., & Field, L. J. (2000) · Circulation Research · doi:10.1161/01.res.86.5.571 · Cited by 260
Poncelet, A.-C., & Schnaper, H. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006442200 · Cited by 227
Biological activities of fibroblast growth factor-2 in the adult myocardium
Detillieux, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00708-3 · Cited by 201
Regulation of cardiovascular collagen synthesis by mechanical load
Bishop, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00021-8 · Cited by 177
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
Brooks, W. W., & Conrad, C. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1065 · Cited by 174
Progression of heart failure: A role for interstitial fibrosis
Sabbah, H. N., Sharov, V. G., Lesch, M., & Goldstein, S. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf00944780 · Cited by 167
Thiedemann, K. U., Holubarsch, C., Medugorac, I., & Jacob, R. (1983) · Basic Research in Cardiology · doi:10.1007/bf01906668 · Cited by 164
Fielitz, J., Hein, S., Mitrovic, V., Pregla, R., Zurbrügg, H. R., Warnecke, C., Schaper, J., Fleck, E., & Regitz-Zagrosek, V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01170-6 · Cited by 162
Connective tissue growth factor and cardiac fibrosis
Daniels, A., Van Bilsen, M., Goldschmeding, R., Van Der Vusse, G. J., & Van Nieuwenhoven, F. A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01936.x · Cited by 161
Zannad, F., Dousset, B., & Alla, F. (2001) · Hypertension · doi:10.1161/hy1101.099484 · Cited by 159
Myocardial Mechanics and Collagen Structure in the Osteogenesis Imperfecta Murine ( oim )
Weis, S. M., Emery, J. L., Becker, K. D., McBride, D. J., Omens, J. H., & McCulloch, A. D. (2000) · Circulation Research · doi:10.1161/01.res.87.8.663 · Cited by 158
Panek, A. N., Posch, M. G., Alenina, N. V., Ghadge, S. K., Erdmann, B., Popova, E., Perrot, A., Geier, C., Dietz, R., Bäder, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006743 · Cited by 141
Periostin as a Heterofunctional Regulator of Cardiac Development and Disease
Conway, S. J., & Molkentin, J. D. (2008) · Current Genomics · doi:10.2174/138920208786847917 · Cited by 134
Koitabashi, N., Arai, M., Kogure, S., Niwano, K., Watanabe, A., Aoki, Y., Maeno, T., Nishida, T., Kubota, S., Takigawa, M., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.077537 · Cited by 132
Altered fibroblast function following myocardial infarction
Squires, C. E., ESCOBAR, G., PAYNE, J., LEONARDI, R., Goshorn, D. K., Sheats, N. J., Mains, I. M., Mingoia, J. T., Flack, E. C., & Lindsey, M. L. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.008 · Cited by 131
Jaffré, F., Bonnin, P., Callebert, J., Debbabi, H., Setola, V., Doly, S., Monassier, L., Mettauer, B., Blaxall, B. C., Launay, J., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.180976 · Cited by 129
Ohnishi, H., Oka, T., Kusachi, S., Nakanishi, T., Takeda, K., Nakahama, M., Doi, M., Murakami, T., Ninomiya, Y., Takigawa, M., et al. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0799 · Cited by 124
Kato, S., Spinale, F. G., Tanaka, R., Johnson, W., Cooper, G., & Zile, M. R. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.3.h863 · Cited by 122
Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts
MacKenna, D. A., Omens, J. H., McCulloch, A. D., & Covell, J. W. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.3.h1007 · Cited by 122
Silver, M. A., Pick, R., Brilla, C. G., Jalil, J., Janicki, J. S., & Weber, K. T. (1990) · Cardiovascular Research · doi:10.1093/cvr/24.9.741 · Cited by 121
Distinct Oligomeric States of SMAD Proteins in the Transforming Growth Factor-β Pathway
Jayaraman, L., & Massagué, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005799200 · Cited by 119
Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
Agarwal, R., Siva, S., Dunn, S., & Sharma, K. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31392 · Cited by 109
Connective Tissue Growth Factor Is Increased in Plasma of Type 1 Diabetic Patients With Nephropathy
Roestenberg, P., van Nieuwenhoven, F. A., Wieten, L., de Boer, P., Diekman, T., Tiller, A. M., Wiersinga, W. M., Oliver, N., Usinger, W. R., Weitz, S., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1164 · Cited by 108
Wang, B., Haldar, S. M., Lu, Y., Ibrahim, O. A., Fisch, S., Gray, S., Leask, A., & Jain, M. K. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.005 · Cited by 107
N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma
Dziadzio, M., Usinger, W. R., Leask, A., Abraham, D., Black, C. M., Denton, C. P., & Stratton, R. J. (2005) · QJM · doi:10.1093/qjmed/hci078 · Cited by 100
The TGFβ superfamily in myocardium: Ligands, receptors, transduction, and function
BRAND, T., & Schneider, M. D. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80003-x · Cited by 98
Jalil, J. (1988) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(88)90597-4 · Cited by 97
Myocardial hypertrophy in Macaca fascicularis. Structural remodeling of the collagen matrix.
Abrahams, C., Janicki, J. S., & Kt, W. (1987) · PubMed · Cited by 85
Villar, A. V., Llano, M., Cobo, M., Expósito, V., Merino, R., Martín‐Durán, R., Hurlé, M. A., & Nistal, J. F. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.024 · Cited by 79
Bing, O. H. L., Fanburg, B. L., Brooks, W. W., & Matsushita, S. (1978) · Circulation Research · doi:10.1161/01.res.43.4.632 · Cited by 77
El‐Agroudy, A. E., Hassan, N. M. A. E.-F., Bakr, M. A., Foda, M. A., Shokeir, A. A., El‐Din, A. B. S., & Ghoneim, M. A. (2003) · American Journal of Nephrology · doi:10.1159/000072819 · Cited by 73
Watsky, M. A., Weber, K. T., Sun, Y., & Postlethwaite, A. E. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)82004-0 · Cited by 71
Li, J., & Brooks, G. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0457 · Cited by 67
Matrix gene expression and decompensated heart failure The aged SHR model
Boluyt, M. O., & Bing, O. H. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00043-2 · Cited by 67
de Boer, R. A., Pokharel, S., Flesch, M., van Kampen, D. A., Suurmeijer, A. J. H., Boomsma, F., van Gilst, W. H., van Veldhuisen, D. J., & Pinto, Y. M. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0579-3 · Cited by 60
Self-citationKemp, T. J., Aggeli, I.-K., Sugden, P. H., & Clerk, A. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.04.022 · Cited by 59
Flack, E. C., Lindsey, M. L., Squires, C. E., Kaplan, B. S., Stroud, R. E., Clark, L. L., Escobar, P. G., Yarbrough, W. M., & Spinale, F. G. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.01.019 · Cited by 50
Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension
Hocher, B., Godes, M., Olivier, J., Weil, J., Thomas Eschenhagen, A., Slowinski, T., Neumayer, H., Bauer, C., Paul, M., & Pinto, Y. M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200204000-00034 · Cited by 40
Self-citationMutation in collagen gene induces cardiomyopathy in transgenic mice*
Miller, A. D., & Tyagi, S. C. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10130 · Cited by 21
Cited by
Braunwald, E. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.10.002 · Cited by 730
Ronco, C., Cicoira, M., & McCullough, P. A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.077 · Cited by 422
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Heart failure with preserved ejection fraction: from mechanisms to therapies
Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355
Metadata
- Authors
- Creemers, E. E., & Pinto, Y. M.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-28
- Volume
- 89
- Issue
- 2
- Pages
- 265-272
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2171820373
- Cited by
- 403
- References
- 81
- FWCI
- 17.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.